LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 110 filers reported holding LEXICON PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $545 | -52.4% | 500 | 0.0% | 0.00% | – |
Q2 2023 | $1,145 | -5.8% | 500 | 0.0% | 0.00% | – |
Q1 2023 | $1,215 | +27.2% | 500 | 0.0% | 0.00% | – |
Q4 2022 | $955 | -4.5% | 500 | 0.0% | 0.00% | – |
Q3 2022 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
Q2 2022 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
Q1 2022 | $1,000 | -50.0% | 500 | 0.0% | 0.00% | – |
Q4 2021 | $2,000 | 0.0% | 500 | 0.0% | 0.00% | – |
Q3 2021 | $2,000 | 0.0% | 500 | 0.0% | 0.00% | – |
Q2 2021 | $2,000 | -33.3% | 500 | 0.0% | 0.00% | – |
Q1 2021 | $3,000 | +50.0% | 500 | 0.0% | 0.00% | – |
Q4 2020 | $2,000 | +100.0% | 500 | 0.0% | 0.00% | – |
Q3 2020 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
Q2 2020 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
Q1 2020 | $1,000 | -50.0% | 500 | 0.0% | 0.00% | – |
Q4 2019 | $2,000 | 0.0% | 500 | 0.0% | 0.00% | – |
Q3 2019 | $2,000 | -71.4% | 500 | -55.1% | 0.00% | – |
Q2 2019 | $7,000 | +16.7% | 1,113 | 0.0% | 0.00% | – |
Q1 2019 | $6,000 | -14.3% | 1,113 | 0.0% | 0.00% | – |
Q4 2018 | $7,000 | -46.2% | 1,113 | -5.6% | 0.00% | – |
Q3 2018 | $13,000 | -97.3% | 1,179 | -97.1% | 0.00% | -100.0% |
Q2 2018 | $484,000 | +32.6% | 40,337 | -5.4% | 0.00% | +50.0% |
Q1 2018 | $365,000 | -12.3% | 42,643 | +1.3% | 0.00% | -33.3% |
Q4 2017 | $416,000 | -20.2% | 42,100 | -0.7% | 0.00% | -25.0% |
Q3 2017 | $521,000 | -26.1% | 42,385 | -1.2% | 0.00% | -33.3% |
Q2 2017 | $705,000 | +19.1% | 42,885 | +3.9% | 0.01% | +20.0% |
Q1 2017 | $592,000 | +9.0% | 41,270 | +5.0% | 0.01% | -16.7% |
Q4 2016 | $543,000 | -11.4% | 39,288 | -8.0% | 0.01% | -33.3% |
Q2 2016 | $613,000 | +18.1% | 42,705 | -1.6% | 0.01% | +12.5% |
Q1 2016 | $519,000 | -4.9% | 43,419 | +5.8% | 0.01% | -27.3% |
Q4 2015 | $546,000 | +10.8% | 41,033 | -10.6% | 0.01% | -8.3% |
Q3 2015 | $493,000 | +183.3% | 45,897 | +112.5% | 0.01% | +140.0% |
Q2 2015 | $174,000 | – | 21,597 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ulys, L.L.C. | 4,321,214 | $34,786,000 | 99.98% |
Artal Group S.A. | 57,517,978 | $463,019,000 | 19.93% |
MASTERS CAPITAL MANAGEMENT LLC | 1,129,708 | $9,094,000 | 0.30% |
Rhenman & Partners Asset Management AB | 170,915 | $1,376,000 | 0.16% |
Round Table Services, LLC | 21,611 | $174,000 | 0.14% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $287,000 | 0.10% |
FALCON POINT CAPITAL, LLC | 37,039 | $298,000 | 0.10% |
SABBY MANAGEMENT, LLC | 318,775 | $2,566,000 | 0.09% |
WILLIAM HARRIS INVESTORS INC | 39,495 | $318,000 | 0.09% |
HOWARD HUGHES MEDICAL INSTITUTE | 51,520 | $415,000 | 0.09% |